Form 4: Ryan Specialty CFO Receives Stock Option Grant
Insider Transaction Report
Ryan Specialty Holdings CFO Janice M. Hamilton was granted 33,715 stock options exercisable at $29.66 per share.
Summary
- Janice M. Hamilton, Chief Financial Officer of Ryan Specialty Holdings, Inc., received a grant of 33,715 stock options.
- The options have an exercise price of $29.66 per share.
- The options are set to expire on May 5, 2036.
- The grant was approved by the compensation and governance committee.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that does not signal a change in company fundamentals.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon exercise.
Risks
- Market price volatility could impact the future value of the granted options.
Future Outlook
The options vest in equal installments on July 1, 2029, 2030, and 2031, indicating a long-term retention strategy for the CFO.
Management Comments
- The grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).
Industry Context
StockSavvy.ai notes that equity grants for C-suite executives are standard practice in the insurance brokerage sector to ensure leadership retention and performance alignment.
Comparison to Industry Standards
- The vesting schedule (2029-2031) is consistent with long-term incentive plans seen at peers like Marsh & McLennan and Aon.
- The use of stock options as a primary retention tool remains a common benchmark for executive compensation in the financial services industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | Grant of stock options to the CFO approved by the compensation and governance committee. | 05/05/2026 | Standard compensation practice; no material change to governance structure. |
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise of these options.
Next Steps
- Vesting of options beginning July 1, 2029.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Date of the stock option grant transaction. |
| 05/07/2026 | Date the Form 4 was filed with the SEC. |
| 07/01/2029 | Initial vesting date for the granted options. |
| 05/05/2036 | Expiration date of the stock options. |
Keywords
Ryan Specialty, RYAN, Form 4, Insider Trading, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.